Home LiteratureArticle Details
PMID: 12874240 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Injury primes the innate immune system for enhanced Toll-like receptor reactivity.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 171 ·No. 3 ·2003-08-01 ·Pages 1473-83

Paterson HM, Murphy TJ, Purcell EJ, Shelley O, Kriynovich SJ, Lien E, Mannick JA, Lederer JA

Abstract

Severe injury causes a dramatic host response that disrupts immune homeostasis and predisposes the injured host to opportunistic infections. Because Toll-like receptors (TLRs) recognize conserved microbial Ags and endogenous danger signals that may be triggered by injury, we wanted to determine how injury influences TLR responses. Using an in vivo injury model, we demonstrate that injury significantly increased TLR2- and TLR4-induced IL-1beta, IL-6, and TNF-alpha production by spleen cells. This influence of injury on TLR reactivity was observed as early as 1 day after injury and persisted for at least 7 days. The outcome of similar studies performed using TLR4-mutant C57BL/10ScN/Cr mice revealed that TLR2 responses remained primed, thus suggesting that injury-induced priming can occur independently of endogenous TLR4 signaling. Increased TLR4 reactivity was also observed in vivo, because LPS-challenged injured mice demonstrated significantly higher cytokine expression levels in the lung, liver, spleen, and plasma. Macrophages and dendritic cells were the major source of these cytokines as judged by intracellular cytokine staining. Moreover, ex vivo studies using enriched macrophage and dendritic cell populations confirmed that T cells did not contribute to the enhanced TLR2 and TLR4 responses. The results of flow cytometry studies using TLR2- and TLR4-MD-2-specific Abs indicated that injury did not markedly alter cell surface TLR2 or TLR4-MD-2 expression. Taken together, these findings establish that injury primes the innate immune system for enhanced TLR2- and TLR4-mediated responses and provides evidence to suggest that augmented TLR reactivity might contribute to the development of heightened systemic inflammation following severe injury.

MeSH Terms
Adjuvants, Immunologic/biosynthesis,physiology Animals Antigens, Ly/biosynthesis Burns/immunology,metabolism,microbiology,pathology Cell Membrane/immunology,metabolism,microbiology Cytokines/biosynthesis Dendritic Cells/immunology,metabolism,microbiology Disease Models, Animal Immune System/cytology,immunology,injuries,metabolism Immunity, Innate Interleukin-1/biosynthesis Lymphocyte Antigen 96 Macrophages/immunology,metabolism,microbiology Male Membrane Glycoproteins/biosynthesis,physiology Mice Mice, Inbred C57BL Mice, Nude Receptors, Cell Surface/biosynthesis,physiology Toll-Like Receptor 2 Toll-Like Receptor 4 Toll-Like Receptors Tumor Necrosis Factor-alpha/biosynthesis Up-Regulation/immunology
Chemicals
Adjuvants, Immunologic Antigens, Ly Cytokines Interleukin-1 Ly96 protein, mouse Lymphocyte Antigen 96 Membrane Glycoproteins Receptors, Cell Surface Toll-Like Receptor 2 Toll-Like Receptor 4 Toll-Like Receptors Tumor Necrosis Factor-alpha
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Paterson Hugh M
Department of Surgery, Brigham and Women's Hospital/Harvard Medical School, Boston, MA 02115, USA.
Murphy Thomas J
Purcell Elizabeth J
Shelley Odhran
Kriynovich Sara J
Lien Egil
Mannick John A
Lederer James A
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
2003-08-01
Pages
1473-83
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NIGMS NIH HHS · GM35663 · United States
NIGMS NIH HHS · GM57664 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com